Key Points
-
The population of adults with congenital heart disease is increasing owing to the improved survival of paediatric patients with these conditions
-
Physicians with expertise in performing interventions in patients with congenital structural lesions are needed
-
Treatment of patients with congenital and acquired structural heart disease requires specialized catheterization laboratories, the integration of imaging modalities, and a collaborative multidisciplinary model for patient care and decision-making
-
With continued advancement in interventional technology and techniques, the use of minimally invasive and percutaneous interventions in this population of patients is expected to grow
Abstract
Interventional cardiac catheterization has become an integral component of the management of adults with congenital heart disease. The origins of this approach come from the paediatric interventional experience, although techniques and indications for interventional cardiac catheterization in adults are now being developed for use in the burgeoning field of adult congenital heart disease. Progress in the application and acceptance of interventional cardiac catheterization in this setting has been swift, and the pace is quickening. This Review provides a broad overview of some of the most common procedures used in the treatment of adults with congenital heart lesions, with an emphasis on new tools that have revolutionized the field. Specifically, we discuss interventions that can be broadly classified into the following groups: techniques for closing shunt lesions, valvular interventions, methods for achieving patency of vascular obstructions, and selected additional interventions applicable to some complex lesions. We emphasize the need for a thorough understanding of the anatomy of the lesion, its natural or unnatural history, and indications for intervention before the procedure takes place. Such procedures must be performed in centres where the operators are knowledgeable of the lesions being addressed, with full surgical, anaesthetic, nursing and imaging support.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miller, G. W. King of Hearts: the True Story of the Maverick who Pioneered Open-Heart Surgery (Times Books, 2000).
Stuart, A. G. Changing lesion demographics of the adult with congenital heart disease: an emerging population with complex needs. Future Cardiol. 8, 305–313 (2012).
Warnes, C. A. et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 118, e714–e833 (2008).
Silversides, C. K. et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can. J. Cardiol. 26, 143–150 (2010).
Baumgartner, H. et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur. Heart J. 31, 2915–2957 (2010).
Meadows, J. & Landzberg, M. J. Advances in transcatheter interventions in adults with congenital heart disease. Prog. Cardiovasc. Dis. 53, 265–273 (2011).
Singh, H. S., Osten, M. & Horlick, E. Future horizons for catheter-based interventions in adult congenital and structural heart disease. Future Cardiol. 8, 203–213 (2012).
Chen, S. J., Hansgen, A. R. & Carroll, J. D. The future cardiac catheterization laboratory. Cardiol. Clin. 27, 541–548 (2009).
Lindsey, J. B. & Hillis, L. D. Clinical update: atrial septal defect in adults. Lancet 369, 1244–1246 (2007).
Amin, Z. Transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc. Interv. 68, 778–787 (2006).
King, T. D., Thompson, S. L., Steiner, C. & Mills, N. L. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 235, 2506–2509 (1976).
Kotowycz, M. A. et al. Long-term outcomes after surgical versus transcatheter closure of atrial septal defects in adults. JACC Cardiovasc. Interv. 6, 497–503 (2013).
Gupta, S. K. et al. Trans-catheter closure of atrial septal defect: Balloon sizing or no Balloon sizing—single centre experience. Ann. Pediatr. Cardiol. 4, 28–33 (2011).
Spence, M. S. & Qureshi, S. A. Complications of transcatheter closure of atrial septal defects. Heart 91, 1512–1514 (2005).
Yared, K. et al. Echocardiographic assessment of percutaneous patent foramen ovale and atrial septal defect closure complications. Circ. Cardiovasc. Imaging 2, 141–149 (2009).
Moore, J. et al. Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc. Interv. 6, 433–442 (2013).
Crawford, G. B., Brindis, R. G., Krucoff, M. W., Mansalis, B. P. & Carroll, J. D. Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature. Catheter Cardiovasc. Interv. 80, 157–167 (2012).
Martin, G. R. et al. The IMPACT registry: IMproving Pediatric and Adult Congenital Treatments. Semin. Thorac. Cardiovasc. Surg. Pediatr. Card. Surg. Annu. 13, 20–25 (2010).
Papadopoulos, G. et al. Venous and paradoxical air embolism in the sitting position. A prospective study with transoesophageal echocardiography. Acta Neurochir (Wien) 126, 140–143 (1994).
Schwerzmann, M. et al. Atrial septal defect closure in a patient with “irreversible” pulmonary hypertensive arteriopathy. Int. J. Cardiol. 110, 104–107 (2006).
Schneider, H. E., Jux, C., Kriebel, T. & Paul, T. Fate of a modified fenestration of atrial septal occluder device after transcatheter closure of atrial septal defects in elderly patients. J. Interv. Cardiol. 24, 485–490 (2011).
Silversides, C. K. et al. Predictors of atrial arrhythmias after device closure of secundum type atrial septal defects in adults. Am. J. Cardiol. 101, 683–687 (2008).
Kutty, S. et al. Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect. Am. J. Cardiol. 109, 1348–1352 (2012).
Ewert, P., Berger, F., Nagdyman, N., Kretschmar, O. & Lange, P. E. Acute left heart failure after interventional occlusion of an atrial septal defect [German]. Z. Kardiol. 90, 362–366 (2001).
Hagen, P. T., Scholz, D. G. & Edwards, W. D. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin. Proc. 59, 17–20 (1984).
Calvert, P. A., Rana, B. S., Kydd, A. C. & Shapiro, L. M. Patent foramen ovale: anatomy, outcomes, and closure. Nat. Rev. Cardiol. 8, 148–160 (2011).
Rana, B. S., Thomas, M. R., Calvert, P. A., Monaghan, M. J. & Hildick-Smith, D. Echocardiographic evaluation of patent foramen ovale prior to device closure. JACC Cardiovasc. Imaging 3, 749–760 (2010).
Rigatelli, G. et al. ICE-guided patent foramen ovale (PFO) closure with lastest-generation devices: the ideal strategy for PFO-related migraine? J. Cardiovasc. Med. (Hagerstown) 8, 633–635 (2007).
Roger, V. L. et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123, e18–e209 (2011).
Kolominsky-Rabas, P. L., Weber, M., Gefeller, O., Neundoerfer, B. & Heuschmann, P. U. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32, 2735–2740 (2001).
Sacco, R. L. et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann. Neurol. 25, 382–390 (1989).
Tobis, J. & Shenoda, M. Percutaneous treatment of patent foramen ovale and atrial septal defects. J. Am. Coll. Cardiol. 60, 1722–1732 (2012).
Lechat, P. et al. Prevalence of patent foramen ovale in patients with stroke. N. Engl. J. Med. 318, 1148–1152 (1988).
Mas, J. L. et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med. 345, 1740–1746 (2001).
Mas, J. L. Patent foramen ovale, atrial septal aneurysm and ischaemic stroke in young adults. Eur. Heart J. 15, 446–449 (1994).
Ramani, G. V., Kligerman, S. & Lehr, E. Multimodality imaging of thrombus in transit crossing a patent foramen ovale. J. Am. Coll. Cardiol. 59, e19 (2012).
Taaffe, M. et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am. J. Cardiol. 101, 1353–1358 (2008).
Wahl, A. et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 125, 803–812 (2012).
Carroll, J. D. et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N. Engl. J. Med. 386, 1092–1100 (2013).
Khairy, P., O'Donnell, C. P. & Landzberg, M. J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med. 139, 753–760 (2003).
Furlan, A. J. et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N. Engl. J. Med. 366, 991–999 (2012).
Meier, B. et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N. Engl. J. Med. 368, 1083–1091 (2013).
Billinger, M. et al. Patent foramen ovale closure in recreational divers: effect on decompression illness and ischaemic brain lesions during long-term follow-up. Heart 97, 1932–1937 (2011).
Landzberg, M. J. et al. Orthodeoxia-platypnea due to intracardiac shunting--relief with transcatheter double umbrella closure. Cathet. Cardiovasc. Diagn. 36, 247–250 (1995).
Rigatelli, G. et al. Incidence of extracerebral paradoxical embolisms in patients with intracardiac shunts. Cardiovasc. Revasc. Med. 8, 248–250 (2007).
Dowson, A. et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 117, 1397–1404 (2008).
Minette, M. S. & Sahn, D. J. Ventricular septal defects. Circulation 114, 2190–2197 (2006).
Ooshima, A., Fukushige, J. & Ueda, K. Incidence of structural cardiac disorders in neonates: an evaluation by color Doppler echocardiography and the results of a 1-year follow-up. Cardiology 86, 402–406 (1995).
Lock, J. E., Block, P. C., McKay, R. G., Baim, D. S. & Keane, J. F. Transcatheter closure of ventricular septal defects. Circulation 78, 361–368 (1988).
Janorkar, S., Goh, T. & Wilkinson, J. Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc. Interv. 46, 43–48 (1999).
Kalra, G. S., Verma, P. K., Singh, S. & Arora, R. Transcatheter closure of ventricular septal defect using detachable steel coil. Heart 82, 395–396 (1999).
Knauth, A. L. et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 110, 501–507 (2004).
Latiff, H. A., Alwi, M., Kandhavel, G., Samion, H. & Zambahari, R. Transcatheter closure of multiple muscular ventricular septal defects using Gianturco coils. Ann. Thorac. Surg. 68, 1400–1401 (1999).
Sideris, E. B. et al. Occlusion of congenital ventricular septal defects by the buttoned device. “Buttoned device” Clinical Trials International Register. Heart 77, 276–279 (1997).
Holzer, R. et al. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U. S. registry. J. Am. Coll. Cardiol. 43, 1257–1263 (2004).
Al-Kashkari, W., Balan, P., Kavinsky, C. J., Cao, Q. L. & Hijazi, Z. M. Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients. Catheter Cardiovasc. Interv. 77, 260–267 (2011).
Bacha, E. A. et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr. Cardiol. 26, 169–175 (2005).
Carminati, M. et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur. Heart J. 28, 2361–2368 (2007).
Szkutnik, M., Qureshi, S. A., Kusa, J., Rosenthal, E. & Bialkowski, J. Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart 93, 355–358 (2007).
Koneti, N. R. et al. Transcatheter retrograde closure of perimembranous ventricular septal defects in children with the Amplatzer duct occluder II device. J. Am. Coll. Cardiol. 60, 2421–2422 (2012).
Chungsomprasong, P., Durongpisitkul, K., Vijarnsorn, C., Soongswang, J. & Le, T. P. The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil. Catheter Cardiovasc. Interv. 78, 1032–1040 (2011).
Velasco-Sanchez, D., Tzikas, A., Ibrahim, R. & Miro, J. Transcatheter closure of perimembranous ventricular septal defects: Initial human experience with the Amplatzer® membranous VSD occluder 2. Catheter Cardiovasc. Interv. http://dx.doi.org/10.1002/ccd.24361.
El Said, H. G., Bratincsak, A., Gordon, B. M. & Moore, J. W. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the amplazter duct occluder I: Lessons learned and medium term follow up. Catheter Cardiovasc. Interv. 80, 895–903 (2012).
Schneider, D. J. The patent ductus arteriosus in term infants, children, and adults. Semin. Perinatol. 36, 146–153 (2012).
Masura, J. et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J. Am. Coll. Cardiol. 31, 878–882 (1998).
Wang, J. K. et al. A strategic approach to transcatheter closure of patent ductus: Gianturco coils for small-to-moderate ductus and Amplatzer duct occluder for large ductus. Int. J. Cardiol. 106, 10–15 (2006).
Donti, A. et al. Transcatheter closure of the patent ductus arteriosus with new-generation devices: comparative data and follow-up results. Ital. Heart J. 3, 122–127 (2002).
Pass, R. H., Hijazi, Z., Hsu, D. T., Lewis, V. & Hellenbrand, W. E. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J. Am. Coll. Cardiol. 44, 513–519 (2004).
Rao, P. S. Percutaneous balloon pulmonary valvuloplasty: state of the art. Catheter Cardiovasc. Interv. 69, 747–763 (2007).
Hayes, C. J. et al. Second natural history study of congenital heart defects. Results of treatment of patients with pulmonary valvar stenosis. Circulation 87, I28–I37 (1993).
Chen, C. R. et al. Percutaneous balloon valvuloplasty for pulmonic stenosis in adolescents and adults. N. Engl. J. Med. 335, 21–25 (1996).
Fawzy, M. E. et al. Long-term results (up to 17 years) of pulmonary balloon valvuloplasty in adults and its effects on concomitant severe infundibular stenosis and tricuspid regurgitation. Am. Heart J. 153, 433–438 (2007).
Kaul, U. A. et al. Long-term results after balloon pulmonary valvuloplasty in adults. Am. Heart J. 126, 1152–1155 (1993).
Sadr-Ameli, M. A., Sheikholeslami, F., Firoozi, I. & Azarnik, H. Late results of balloon pulmonary valvuloplasty in adults. Am. J. Cardiol. 82, 398–400 (1998).
Stanger, P. et al. Balloon pulmonary valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am. J. Cardiol. 65, 775–783 (1990).
Thapar, M. K. & Rao, P. S. Significance of infundibular obstruction following balloon valvuloplasty for valvar pulmonic stenosis. Am. Heart J. 118, 99–103 (1989).
Siu, S. C. & Silversides, C. K. Bicuspid aortic valve disease. J. Am. Coll. Cardiol. 55, 2789–2800 (2010).
Tzemos, N. et al. Outcomes in adults with bicuspid aortic valves. JAMA 300, 1317–1325 (2008).
Lababidi, Z., Wu, J. R. & Walls, J. T. Percutaneous balloon aortic valvuloplasty: results in 23 patients. Am. J. Cardiol. 53, 194–197 (1984).
McKay, R. G. et al. Assessment of left ventricular and aortic valve function after aortic balloon valvuloplasty in adult patients with critical aortic stenosis. Circulation 75, 192–203 (1987).
Reich, O. et al. Long term results of percutaneous balloon valvoplasty of congenital aortic stenosis: independent predictors of outcome. Heart 90, 70–76 (2004).
Friedman, K. G. et al. Left ventricular remodeling and improvement in diastolic function after balloon aortic valvuloplasty for congenital aortic stenosis. Circ. Cardiovasc. Interv. 5, 549–554 (2012).
Fratz, S. et al. Aortic valvuloplasty in pediatric patients substantially postpones the need for aortic valve surgery: a single-center experience of 188 patients after up to 17.5 years of follow-up. Circulation 117, 1201–1206 (2008).
Sandhu, S. K., Lloyd, T. R., Crowley, D. C. & Beekman, R. H. Effectiveness of balloon valvuloplasty in the young adult with congenital aortic stenosis. Cathet. Cardiovasc. Diagn. 36, 122–127 (1995).
Litvack, F., Jakubowski, A. T., Buchbinder, N. A. & Eigler, N. Lack of sustained clinical improvement in an elderly population after percutaneous aortic valvuloplasty. Am. J. Cardiol. 62, 270–275 (1988).
Beekman, R. H. et al. Comparison of single and double balloon valvuloplasty in children with aortic stenosis. J. Am. Coll. Cardiol. 12, 480–485 (1988).
Karagoz, T. et al. Congenital aortic stenosis: a novel technique for ventricular pacing during valvuloplasty. Catheter Cardiovasc. Interv. 72, 527–530 (2008).
Brown, D. W., Dipilato, A. E., Chong, E. C., Lock, J. E. & McElhinney, D. B. Aortic valve reinterventions after balloon aortic valvuloplasty for congenital aortic stenosis intermediate and late follow-up. J. Am. Coll. Cardiol. 56, 1740–1749 (2010).
Maskatia, S. A. et al. Twenty-five year experience with balloon aortic valvuloplasty for congenital aortic stenosis. Am. J. Cardiol. 108, 1024–1028 (2011).
Khambadkone, S. & Bonhoeffer, P. Nonsurgical pulmonary valve replacement: why, when, and how? Catheter Cardiovasc. Interv. 62, 401–408 (2004).
Bonhoeffer, P. et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 356, 1403–1405 (2000).
Boone, R. H. et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc. Interv. 75, 286–294 (2010).
Lee, C. et al. Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J. Am. Coll. Cardiol. 60, 1005–1014 (2012).
Asoh, K. et al. Percutaneous pulmonary valve implantation within bioprosthetic valves. Eur. Heart J. 31, 1404–1409 (2010).
Roberts, P. A. et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J. Am. Coll. Cardiol. 58, 117–122 (2011).
McElhinney, D. B. et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 122, 507–516 (2010).
Lurz, P. et al. Early versus late functional outcome after successful percutaneous pulmonary valve implantation: are the acute effects of altered right ventricular loading all we can expect? J. Am. Coll. Cardiol. 57, 724–731 (2011).
Lurz, P. et al. Effect of altering pathologic right ventricular loading conditions by percutaneous pulmonary valve implantation on exercise capacity. Am. J. Cardiol. 105, 721–726 (2010).
Vezmar, M. et al. Percutaneous pulmonary valve implantation in the young 2-year follow-up. JACC Cardiovasc. Interv. 3, 439–448 (2010).
Lee, C. et al. Surgical pulmonary valve insertion—when, how, and why. Cardiol. Young 22, 702–707 (2012).
Singh, H. S., Benson, L., Majekodunmi, T., Osten, M. & Horlick, E. Personalized Medicine for Valvular Heart Disease First in Man: Percutaneous Pulmonary Valve-in-Valve Implantation using 29 mm Edwards Sapien Valve. Presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Boudjemline, Y., Agnoletti, G., Bonnet, D., Sidi, D. & Bonhoeffer, P. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract: an experimental study. J. Am. Coll. Cardiol. 43, 1082–1087 (2004).
Rao, P. S. Coarctation of the aorta. Curr. Cardiol. Rep. 7, 425–434 (2005).
Chessa, M. et al. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur. Heart J. 26, 2728–2732 (2005).
Shah, L., Hijazi, Z., Sandhu, S., Joseph, A. & Cao, Q. L. Use of endovascular stents for the treatment of coarctation of the aorta in children and adults: immediate and midterm results. J. Invasive Cardiol. 17, 614–618 (2005).
Krasemann, T., Bano, M., Rosenthal, E. & Qureshi, S. A. Results of stent implantation for native and recurrent coarctation of the aorta-follow-up of up to 13 years. Catheter Cardiovasc. Interv. 78, 405–412 (2011).
San Norberto Garcia, E. M. et al. Open surgical repair and endovascular treatment in adult coarctation of the aorta. Ann. Vasc. Surg. 24, 1068–1074 (2010).
Rodés-Cabau, J. et al. Comparison of surgical and transcatheter treatment for native coarctation of the aorta in patients ≥1 year old. The Quebec Native Coarctation of the Aorta study. Am. Heart J. 154, 186–192 (2007).
Holzer, R. et al. Stenting of aortic coarctation: acute, intermediate, and long-term results of a prospective multi-institutional registry--Congenital Cardiovascular Interventional Study Consortium (CCISC). Catheter Cardiovasc. Interv. 76, 553–563 (2010).
Forbes, T. J. et al. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J. Am. Coll. Cardiol. 58, 2664–2674 (2011).
Golden, A. B. & Hellenbrand, W. E. Coarctation of the aorta: stenting in children and adults. Catheter Cardiovasc. Interv. 69, 289–299 (2007).
Bruckheimer, E., Dagan, T., Amir, G. & Birk, E. Covered Cheatham-Platinum stents for serial dilation of severe native aortic coarctation. Catheter Cardiovasc. Interv. 74, 117–123 (2009).
Tanous, D., Collins, N., Dehghani, P., Benson, L. N. & Horlick, E. M. Covered stents in the management of coarctation of the aorta in the adult: initial results and 1-year angiographic and hemodynamic follow-up. Int. J. Cardiol. 140, 287–295 (2010).
Butera, G., Heles, M., MacDonald, S. T. & Carminati, M. Aortic coarctation complicated by wall aneurysm: the role of covered stents. Catheter Cardiovasc. Interv. 78, 926–932 (2011).
Ringel, R. E., Gauvreau, K., Moses, H. & Jenkins, K. J. Coarctation of the Aorta Stent Trial (COAST): study design and rationale. Am. Heart J. 164, 7–13 (2012).
Goldstein, B. H. et al. Percutaneous balloon-expandable covered stent implantation for treatment of traumatic aortic injury in children and adolescents. Am. J. Cardiol. 110, 1541–1545 (2012).
Prieto, L. R. & Latson, L. A. in Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult 7th edn (eds Moss, A. J. & Allen, H. D.) 849–859 (Lippincott Williams & Wilkins, 2008).
Thomson, J. D. & Qureshi, S. A. Transcatheter rehabilitation of pulmonary arteries. Expert Rev. Cardiovasc. Ther. 9, 1459–1467 (2011).
Gentles, T. L., Lock, J. E. & Perry, S. B. High pressure balloon angioplasty for branch pulmonary artery stenosis: early experience. J. Am. Coll. Cardiol. 22, 867–872 (1993).
Bergersen, L. et al. Randomized trial of cutting balloon compared with high-pressure angioplasty for the treatment of resistant pulmonary artery stenosis. Circulation 124, 2388–2396 (2011).
Krisnanda, C., Menahem, S. & Lane, G. K. Intravascular stent implantation for the management of pulmonary artery stenosis. Heart Lung Circ. 22, 56–70 (2013).
Law, M. A. et al. Pulmonary artery stents: long-term follow-up. Catheter Cardiovasc. Interv. 75, 757–764 (2010).
McMahon, C. J. et al. Redilation of endovascular stents in congenital heart disease: factors implicated in the development of restenosis and neointimal proliferation. J. Am. Coll. Cardiol. 38, 521–526 (2001).
Stapleton, G. E. et al. Simultaneous stent implantation to treat bifurcation stenoses in the pulmonary arteries: Initial results and long-term follow up. Catheter Cardiovasc. Interv. 73, 557–563 (2009).
Zartner, P., Cesnjevar, R., Singer, H. & Weyand, M. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby. Catheter Cardiovasc. Interv. 66, 590–594 (2005).
Mitropoulos, F. A. et al. Intraoperative pulmonary artery stenting: an alternative technique for the management of pulmonary artery stenosis. Ann. Thorac. Surg. 84, 1338–1341; discussion 1342 (2007).
Maglione, J., Bergersen, L., Lock, J. E. & McElhinney, D. B. Ultra-high-pressure balloon angioplasty for treatment of resistant stenoses within or adjacent to previously implanted pulmonary arterial stents. Circ. Cardiovasc. Interv. 2, 52–58 (2009).
Magee, A. G. et al. Systemic venous collateral development after the bidirectional cavopulmonary anastomosis. Prevalence and predictors. J. Am. Coll. Cardiol. 32, 502–508 (1998).
McElhinney, D. B., Reddy, V. M., Hanley, F. L. & Moore, P. Systemic venous collateral channels causing desaturation after bidirectional cavopulmonary anastomosis: evaluation and management. J. Am. Coll. Cardiol. 30, 817–824 (1997).
Gatzoulis, M. A. et al. Increasing cyanosis early after cavopulmonary connection caused by abnormal systemic venous channels. Br. Heart J. 73, 182–186 (1995).
Heinemann, M. et al. Incidence and impact of systemic venous collateral development after Glenn and Fontan procedures. Thorac. Cardiovasc. Surg. 49, 172–178 (2001).
Sugiyama, H., Yoo, S. J., Williams, W. & Benson, L. N. Characterization and treatment of systemic venous to pulmonary venous collaterals seen after the Fontan operation. Cardiol. Young 13, 424–430 (2003).
Uemura, H. et al. Redirection of hepatic venous drainage after total cavopulmonary shunt in left isomerism. Ann. Thorac. Surg. 68, 1731–1735 (1999).
Weber, H. S. Incidence and predictors for the development of significant supradiaphragmatic decompressing venous collateral channels following creation of Fontan physiology. Cardiol. Young 11, 289–294 (2001).
du Plessis, A. J. et al. Cerebrovascular accidents following the Fontan operation. Pediatr. Neurol. 12, 230–236 (1995).
Seltzer, S., Aboulhosn, J. & Levi, D. S. Use of interlock fibered detachable coils for occlusion of collaterals, coronary artery fistulae, and patent ductus arteriosus. Catheter Cardiovasc. Interv. 74, 770–776 (2009).
Sonomura, T. et al. Usefulness of the Guglielmi detachable coil for embolization of a systemic venous collateral after Fontan operation: A case report. World J. Radiol. 4, 418–420 (2012).
Warnes, C. A. Transposition of the great arteries. Circulation 114, 2699–2709 (2006).
Patel, S., Shah, D., Chintala, K. & Karpawich, P. P. Atrial baffle problems following the Mustard operation in children and young adults with dextro-transposition of the great arteries: the need for improved clinical detection in the current era. Congenit. Heart Dis. 6, 466–474 (2011).
Singh, H. S. et al. Complex interventions in the adult with congenital heart disease: Percutaneous solutions for venous baffles, coronary artery fistulas, and ruptured sinus of valsalva aneurysms. Interventional Cardiology Clinics 2, 153–172 (2013).
Asgar, A. W., Miro, J. & Ibrahim, R. Recanalization of systemic venous baffles by radiofrequency perforation and stent implantation. Catheter Cardiovasc. Interv. 70, 591–594 (2007).
Ebeid, M. R. et al. Catheter management of occluded superior baffle after atrial switch procedures for transposition of great vessels. Am. J. Cardiol. 95, 782–786 (2005).
Brown, S. C. et al. Self expandable stents for relief of venous baffle obstruction after the Mustard operation. Heart 79, 230–233 (1998).
Bu'Lock, F. A. et al. Balloon expandable stents for systemic venous pathway stenosis late after Mustard's operation. Heart 79, 225–229 (1998).
Hill, K. D., Fudge, J. C. & Rhodes, J. F. Complete resolution of systemic venous baffle obstruction and baffle leak using the Gore Excluder covered stent in two patients with transposition of the great arteries and prior Mustard procedure. Catheter Cardiovasc. Interv. 76, 878–881 (2010).
Daehnert, I., Hennig, B., Wiener, M. & Rotzsch, C. Interventions in leaks and obstructions of the interatrial baffle late after Mustard and Senning correction for transposition of the great arteries. Catheter Cardiovasc. Interv. 66, 400–407 (2005).
Michel-Behnke, I., Hagel, K. J., Bauer, J. & Schranz, D. Superior caval venous syndrome after atrial switch procedure: relief of complete venous obstruction by gradual angioplasty and placement of stents. Cardiol. Young 8, 443–448 (1998).
Ward, C. J., Mullins, C. E., Nihill, M. R., Grifka, R. G. & Vick, G. W., 3rd. Use of intravascular stents in systemic venous and systemic venous baffle obstructions. Short-term follow-up results. Circulation 91, 2948–2954 (1995).
Author information
Authors and Affiliations
Contributions
H. S. Singh researched the data for the article. H. S. Singh, E. Horlick, M. Osten and L. N. Benson contributed to discussion of the article content and writing the manuscript. H. S. Singh, E. Horlick and M. Osten undertook review and editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Singh, H., Horlick, E., Osten, M. et al. Interventional cardiology in adults with congenital heart disease. Nat Rev Cardiol 10, 662–678 (2013). https://doi.org/10.1038/nrcardio.2013.127
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2013.127
This article is cited by
-
Multimodality Imaging in the Evaluation and Treatment of Pulmonary Valve Disorders
Current Treatment Options in Cardiovascular Medicine (2021)